The
mission of the Tufts Health Care Institute Program on
Opioid Risk Management is to address challenges in the
development and utilization of opioid analgesics, by
engaging a multidisciplinary group of stakeholders focused
on optimizing the benefits of opioid for pain management,
and minimizing their risks, including abuse and diversion.
June 26 & 27, 2008
A Brief History of Urine Drug Testing: Forging a Common Vocabulary
Gary Reisfield, MD , Presentation >>
Opioid Pharmacology and Urine Drug Monitoring
J. David Haddox, DDS, MD, Presentation >>
Pharmacokinetics and Disposition of Urine Drug Monitoring: Comparison of Various Sources for Drug Testing: Urine, Blood, Hair, Saliva
Edward Cone, PhD, Presentation >>
Analytical Methods Used in Urine Drug Monitoring
Judith Stone, PhD, Presentation >>
Ways to Deceive Drug Testing
Ted Shults, Presentation >>
A Review of Outcome Studies and Gaps in the Literature of Urine Drug Monitoring
Joanna Starrels, MD, Presentation >>
Initiatives to Develop Professional Standards for Urine Drug Monitoring
Roger Bertholf, PhD, Presentation >>
Clinical Applications of Urine Drug Monitoring in the Addiction Treatment Setting
John Femino, MD, MS, Presentation >>
Clinical Applications of Urine Drug Monitoring in the Pain Management Setting: Proposed Guidelines
Howard Heit, MD, Presentation >>
Urine Drug Monitoring: Payer Perspectives
Annette Hanson, MD, MBA, Presentation >>
Case Studies in UDM in Paine Management: Handling Problem Patients
Doug Gourlay, MD, Presentation >>
Concurrent Workgroup Breakouts
Breakout Group 1: Guidelines for
the use of (Urine) Drug
Monitoring in Pain Management Presentation >>
Breakout Group 2: Clinical Research Gaps Related to Urine Drug Monitoring
Presentation >>
Breakout Group 3: Ethical issues Presentation >>
|